TGA rules out over-the-counter sales of oral contraceptives The RACGP has consistently opposed any efforts to down-schedule the pill, citing patient safety.
NSW GPs on watch as hospitals placed on red alert In a possible sign of things to come, a surge in Omicron cases means low-risk patients will undergo ‘self-care’ in the community.
Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
RACGP restructures following member feedback The college has enacted a plan to revamp sections of the organisation in what it says is an effort to better serve members.
How vaccine companies are responding to Omicron Scientists are scrambling to test and potentially update their vaccine candidates against the latest COVID variant of concern.
First ever Australian anaphylaxis standard released The new standard emphasises the need for prompt treatment and continuity of patient care between healthcare settings.
TGA updates post-COVID vaccine myocarditis rates As many of Australia’s remaining vaccine-hesitant patients express concerns over rare side effects associated with mRNA vaccines, the TGA has broken down rates of myocarditis cases following Pfizer doses.
Overwhelming member support for college-led training GPs backed a resolution allowing the RACGP to ‘take all actions necessary’ to return general practice training to the college in 2023.
New guide for treating COVID patients at home The RACGP has released home-care guidelines for COVID patients as GPs prepare to take a more active role in community-based care.
Opioid treatment study ‘may impact’ future Australian guidelines Results from a clinical trial of extended-release buprenorphine injections reveal high retention and treatment satisfaction.